Updated
Reviewed
Jun. 23, 2022

Appendix B: Acronyms

Study and Trial Names

Acronym Name
ACTG AIDS Clinical Trials Group
ANRS National Agency for AIDS Research (France)
ARROW Anti-retroviral research for Watoto
ATHENA AIDS Therapy Evaluation in the Netherlands
ATLAS Antiretroviral Therapy as Long-Acting Suppression
ATN Adolescent Trials Network
CHAPAS Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens
CHER Children with HIV Early Antiretroviral Therapy
DIONE A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
FLAIR First Long-Acting Injectable Regimen
HPPM HIV Paediatric Prognostic Markers
HPTN HIV Prevention Trials Network
IMPAACT International Maternal Pediatric Adolescent AIDS Clinical Trials
MOCHA More Options for Children and Adolescents
NEVEREST Nevirapine Resistance Study
PACTG Pediatric AIDS Clinical Trials Group
PENPACT Trial run in collaboration between PENTA and PACTG/IMPAACT
PENTA Paediatric European Network for Treatment of AIDS
PHACS Pediatric HIV/AIDS Cohort Study
PREDICT Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV
PROMOTE PEPFAR PROMise Ongoing Treatment Evaluation
SBIRT Screening, Brief Intervention, and Referral to Treatment
SMILE Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children
START Strategic Timing of AntiRetroviral Treatment

Appendix B: Acronyms

Study and Trial Names

Acronym Name
ACTG AIDS Clinical Trials Group
ANRS National Agency for AIDS Research (France)
ARROW Anti-retroviral research for Watoto
ATHENA AIDS Therapy Evaluation in the Netherlands
ATLAS Antiretroviral Therapy as Long-Acting Suppression
ATN Adolescent Trials Network
CHAPAS Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens
CHER Children with HIV Early Antiretroviral Therapy
DIONE A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
FLAIR First Long-Acting Injectable Regimen
HPPM HIV Paediatric Prognostic Markers
HPTN HIV Prevention Trials Network
IMPAACT International Maternal Pediatric Adolescent AIDS Clinical Trials
MOCHA More Options for Children and Adolescents
NEVEREST Nevirapine Resistance Study
PACTG Pediatric AIDS Clinical Trials Group
PENPACT Trial run in collaboration between PENTA and PACTG/IMPAACT
PENTA Paediatric European Network for Treatment of AIDS
PHACS Pediatric HIV/AIDS Cohort Study
PREDICT Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV
PROMOTE PEPFAR PROMise Ongoing Treatment Evaluation
SBIRT Screening, Brief Intervention, and Referral to Treatment
SMILE Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children
START Strategic Timing of AntiRetroviral Treatment

Download Guidelines